Differentiation of neuro sphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine

被引:22
|
作者
Abbaszadeh, Hojjat-Allah [1 ]
Tiraihi, Taki [1 ,2 ]
Delshad, AliReza [3 ]
Saghedizadeh, Majid [4 ]
Taheri, Taher [2 ]
Kazemi, Hadi [2 ]
Hassoun, Hayder K. [5 ]
机构
[1] Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, Tehran, Iran
[2] Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran
[3] Shahed Univ, Dept Anat, Tehran, Iran
[4] Tarbiat Modares Univ, Sch Basic Sci, Dept Genet, Tehran, Iran
[5] Kufa Univ, Coll Med, Middle Euphrates Neurosci Ctr, Annajaf Al Ashraf, Iraq
来源
TISSUE & CELL | 2014年 / 46卷 / 06期
关键词
BMSCs; NSCs; Oligodendrocyte like cells; Induction; Differentiation; MARROW STROMAL CELLS; IN-VITRO DIFFERENTIATION; ADULT BONE-MARROW; PROGENITOR CELLS; MYELIN; TRANSPLANTATION; MATURATION; INDUCTION; PROLIFERATION;
D O I
10.1016/j.tice.2014.08.003
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
One of the approaches for treating demyelination diseases is cytotherapy, and adult stem cells are potential sources. In this investigation, we tried to increase the yield of oligodendrocyte-like cells (OLCs) by inducing neural stem cells generated from BMSCs-derived neurospheres, which were used for deriving the neural stem cells (NSCs). The latter were induced into OLCs by heregulin, PDGF-AA, bFGF and triiodothyronine (T3). The BMSCs, NS, NSCs and OLCs were characterized by using immunocytochemistry for fibronectin, CD44, CD90, CD45, Oct-4, O4, Olig2, O1 and MBP markers. PDGF receptor alpha. (PDGFR-c), Olig2 and MOG expression were evaluated by RT-PCR. The BMSCs expressed CD44, CD90, CD106 and Oct-4; the NSCs were immunoreactive to nestin and neurofilament 68. Incubation of the NSCs for 4 days with heregulin, PDGF-AA and bFGF resulted in their induction into oligodendrocyte progenitor-like cells (OPLCs), which immunoreacted to O4, Olig2 and O1, while Olig2 and PDGFR-alpha. were detected by RT-PCR. Replacing heregulin, PDGF-AA and bFGF with T3 for 6 days resulted in repression of O4, O1, Olig2 and PDGFR-alpha. The OLCs were co-cultured with motoneurons resulted in induction of MOG and MBP, which were expressed in functional OLCs. The latter can be generated from BMSCs-derive NS with high yield. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:462 / 469
页数:8
相关论文
共 20 条
  • [1] Olig2 overexpression accelerates the differentiation of mouse embryonic stem cells into oligodendrocyte progenitor cells in vitro
    Yao, Ruiqin
    Wang, Bei
    Ren, Chuanlu
    Qu, Xuebin
    Luo, Mengjiao
    Zhang, Qiang
    Wang, Huiping
    Dong, Fuxing
    Wu, Xiuxiang
    Yang, Lihua
    Yu, Hongli
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2014, 56 (07) : 511 - 517
  • [2] Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes
    Copray, Sjef
    Balasubramaniyan, Veerakumar
    Levenga, Josien
    De Bruijn, Jorick
    Liem, Robert
    Boddeke, Erik
    STEM CELLS, 2006, 24 (04) : 1001 - 1010
  • [3] Human Umbilical Cord–derived Mesenchymal Stem Cells into Oligodendrocyte-like Cells using Triiodothyronine as an Inducer: a Rapid and Efficient Protocol
    Sahar Almasi-turk
    Hatef Ghasemi Hamidabadi
    Parviz Farzadinia
    Ali Movahed
    Hooman Salimipour
    Reza Nemati
    Amrollah Roozbehi
    Maryam Nazm Bojnordi
    Shahram Darabi
    Sina Mojaverrostami
    Regenerative Engineering and Translational Medicine, 2023, 9 : 366 - 374
  • [4] Olig2 positive cells derived from hair follicle neural crest stem cells in rats
    Wang, Tao
    Lin, Haiyan
    Liu, Fang
    Zhang, Chuansen
    JOURNAL OF CHEMICAL NEUROANATOMY, 2020, 105
  • [5] One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2
    Chanoumidou, Konstantina
    Hernandez-Rodriguez, Benjamin
    Windener, Farina
    Thomas, Christian
    Stehling, Martin
    Mozafari, Sabah
    Albrecht, Stefanie
    Ottoboni, Linda
    Antel, Jack
    Kim, Kee-Pyo
    Velychko, Sergiy
    Cui, Qiao Ling
    Xu, Yu Kang T.
    Martino, Gianvito
    Winkler, Jurgen
    Scholer, Hans R.
    Baron-Van Evercooren, Anne
    Boespflug-Tanguy, Odile
    Vaquerizas, Juan M.
    Ehrlich, Marc
    Kuhlmann, Tanja
    STEM CELL REPORTS, 2021, 16 (04): : 771 - 783
  • [6] Human Umbilical Cord-derived Mesenchymal Stem Cells into Oligodendrocyte-like Cells using Triiodothyronine as an Inducer: a Rapid and Efficient Protocol
    Almasi-turk, Sahar
    Hamidabadi, Hatef Ghasemi
    Farzadinia, Parviz
    Movahed, Ali
    Salimipour, Hooman
    Nemati, Reza
    Roozbehi, Amrollah
    Bojnordi, Maryam Nazm
    Darabi, Shahram
    Mojaverrostami, Sina
    REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE, 2023, 9 (03) : 366 - 374
  • [7] Bioinspired Nanofiber Scaffold for Differentiating Bone Marrow-Derived Neural Stem Cells to Oligodendrocyte-Like Cells: Design, Fabrication, and Characterization
    Boroojeni, Fatemeh Rasti
    Mashayekhan, Shohreh
    Abbaszadeh, Hojjat-Allah
    Ansarizadeh, Mohamadhasan
    Khoramgah, Maryam-Sadat
    Movaghar, Vafa Rahimi
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 3903 - 3920
  • [8] Overexpression of Olig2 promotes differentiation of neural stem cells into oligodendrocytes only in non-inflammatory conditions
    Malvandi, A. M.
    Ottoboni, L.
    Merlini, A.
    Butti, E.
    Martino, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 276 - 276
  • [9] Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation
    Setoguchi, T
    Kondo, T
    JOURNAL OF CELL BIOLOGY, 2004, 166 (07): : 963 - 968
  • [10] Mouse Neural Stem Cell Differentiation and Human Adipose Mesenchymal Stem Cell Transdifferentiation Into Neuron-and Oligodendrocyte-like Cells With Myelination Potential
    Santos, Anderson K.
    Gomes, Katia N.
    Parreira, Ricardo C.
    Scalzo, Sergio
    Pinto, Mauro C. X.
    Santiago, Helton C.
    Birbrair, Alexander
    Sack, Ulrich
    Ulrich, Henning
    Resende, Rodrigo R.
    STEM CELL REVIEWS AND REPORTS, 2022, 18 (02) : 732 - 751